ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 39367162

KRAS mutations detection methodology: from RFLP to CRISPR/Cas based methods.

Morshedzadeh F and 3 others. Funct Integr Genomics, 2024. Cited by 2 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. KRAS mutations detection methodology: from RFLP to CRISPR/Cas based methods. Papers, record 39367162. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39367162

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
KRAS mutations detection methodology: from RFLP to CRISPR/Cas based methods.
PubMed
Journal
Funct Integr Genomics
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.23, provisional
iCite
Revised in PubMed
2026-11-01
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Morshedzadeh FFirouzeh
2Abbaszadegan MRMohammad Reza
3Peymani MMaryam
4Mozaffari-Jovin SSina

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Proto-Oncogene Proteins p21(ras)Major topic
MutationMajor topic
CRISPR-Cas SystemsMajor topic
NeoplasmsMajor topic
Humans
High-Throughput Nucleotide Sequencing

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References75

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127,335,808Diagnostic RAS mutation analysis by polymerase chain reaction (PCR).Biomol Detect Quantif2016https://conductscience.org/library/papers/27335808PubMed
232,329,932Improvement of digital PCR conditions for direct detection of KRAS mutations.J Clin Lab Anal2020https://conductscience.org/library/papers/32329932PubMed
337,269,466An Update on the Application of CRISPR Technology in Clinical Practice.Mol Biotechnol2024https://conductscience.org/library/papers/37269466PubMed
420,007,845KRAS mutation: comparison of testing methods and tissue sampling techniques in colon cancer.J Mol Diagn2010https://conductscience.org/library/papers/20007845PubMed
532,725,342Molecular epidemiology and diagnostics of KRAS mutations in human cancer.Cancer Metastasis Rev2020https://conductscience.org/library/papers/32725342PubMed
624,726,492Multiplex detection of KRAS mutations by a matrix-assisted laser desorption/ionization-time of flight mass spectrometry assay.Clin Biochem2014https://conductscience.org/library/papers/24726492PubMed
723,264,846KRAS Testing: A Tool for the Implementation of Personalized Medicine.Genes Cancer2012https://conductscience.org/library/papers/23264846PubMed
833,835,761CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.J Zhejiang Univ Sci B2021https://conductscience.org/library/papers/33835761PubMed
921,745,016Laboratory methods for KRAS mutation analysis.Expert Rev Mol Diagn2011https://conductscience.org/library/papers/21745016PubMed
1035,303,879Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments.Mol Cancer2022https://conductscience.org/library/papers/35303879PubMed

1 to 10 of 75

See all 75 references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42,681,653KRAS signaling networks, mutational heterogeneity, and emerging therapeutic strategies for cancer treatment.Biomark Res2026https://conductscience.org/library/papers/42681653PubMed
41,432,785Integrating single-cell and bulk RNA-Seq to unravel the molecular mechanisms of airway stenosis.Funct Integr Genomics2025https://conductscience.org/library/papers/41432785PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
KRAS3,845PubTator's text mininghttps://conductscience.org/library/genes/3845

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39367162

GET https://conductscience.org/api/papers/v1/39367162/references?page=2

API referenceFor AI assistants